Sofinnova Investments’s Ascendis Pharma A/S ASND Stock Holding History

Sofinnova Investments’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-734,284	Closed	-$100M	–	67
2024 Q2	$100M	Sell	734,284 -19,748	-3%	-$2.69M	5.2%	4
2024 Q1	$114M	Hold	754,032	–	–	6.35%	3
2023 Q4	$95M	Hold	754,032	–	–	5.31%	4
2023 Q3	$70.6M	Hold	754,032	–	–	4.45%	5
2023 Q2	$67.3M	Hold	754,032	–	–	4.41%	5
2023 Q1	$80.8M	Sell	754,032 -126,768	-14%	-$14.5M	5.17%	5
2022 Q4	$108M	Buy	880,800 +380,976	+76%	+$44.2M	6.38%	4
2022 Q3	$51.6M	Hold	499,824	–	–	3%	6
2022 Q2	$46.5M	Hold	499,824	–	–	3.87%	5
2022 Q1	$58.7M	Hold	499,824	–	–	4.45%	7
2021 Q4	$67.2M	Hold	499,824	–	–	3.93%	5
2021 Q3	$79.7M	Sell	499,824 -22,099	-4%	-$3.02M	4.72%	3
2021 Q2	$68.7M	Hold	521,923	–	–	3.96%	5
2021 Q1	$67.3M	Sell	521,923 -587,951	-53%	-$89.4M	4.04%	4
2020 Q4	$185M	Hold	1,109,874	–	–	11.02%	3
2020 Q3	$171M	Hold	1,109,874	–	–	12.7%	2
2020 Q2	$164M	Hold	1,109,874	–	–	10.35%	2
2020 Q1	$125M	Hold	1,109,874	–	–	11.56%	2
2019 Q4	$154M	Hold	1,109,874	–	–	11.13%	1
2019 Q3	$107M	Buy	1,109,874 +10,050	+0.9%	+$1.12M	9.67%	1
2019 Q2	$127M	Buy	1,099,824 +101,286	+10%	+$12.1M	11.64%	1
2019 Q1	$118M	Sell	998,538 -500,000	-33%	-$43.8M	11.33%	1
2018 Q4	$93.9M	Sell	1,498,538 -980,976	-40%	-$61.6M	11.7%	1
2018 Q3	$176M	Hold	2,479,514	–	–	15.66%	1
2018 Q2	$165M	Hold	2,479,514	–	–	18.69%	1
2018 Q1	$162M	Buy	+2,479,514	New	+$139M	27.87%	1

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Sofinnova Investments's ASND Position: Q3 2024 in Review

Sofinnova Investments sold out of Ascendis Pharma A/S (ASND) in Q3 2024, closing a stake of 734,284 shares — an estimated $100M sold.

Sofinnova Investments first reported a position in ASND in Q1 2018 and held it in 26 quarters. The position peaked at $185M in Q4 2020. 219 funds tracked by Wall St. Rank hold ASND as of Q3 2024.

Sofinnova Investments reported no remaining Ascendis Pharma A/S position as of Q3 2024 after selling out during the quarter.
Sofinnova Investments sold 734,284 Ascendis Pharma A/S shares in Q3 2024, an estimated $100M.
Sofinnova Investments first reported a position in Ascendis Pharma A/S in Q1 2018 and held it in 26 quarters.
Sofinnova Investments's Ascendis Pharma A/S position peaked at $185M in Q4 2020.
219 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2024.

Based on Sofinnova Investments's 13F filing for Q3 2024, filed 13 Nov 2024.